Canada announced $20 million in federal investment through Genome Canada and regional Genome Centres to launch 33 new genomics R&D projects across the country.

Spanning applications from AI-powered precision cancer care to helping farmers target drought-tolerant canola crops, these industry-academic partnerships are designed to accelerate adoption of genomics in sectors critical to Canadian health and economic competitiveness.

The investment will generate more than $45 million in additional private and other public sector co-investment—demonstrating how targeted federal funding can catalyze broader business growth, job creation and the deployment of genomics-enabled technologies at scale.

...

Made through Genome Canada’s Genomic Applications Partnership Program (GAPP), this investment will support projects aimed at delivering:

• Faster, more precise diagnoses and personalized care for cancer, rare and chronic diseases
• Accelerated, cost-effective drug development
• New therapies for currently incurable diseases
• Healthier, higher-yield crops for stronger food security
• Improved food safety and reduced agri-food waste
• Lower emissions and greater resilience in agriculture and livestock
• Smarter, faster ecosystem monitoring
• More efficient pollution cleanup

...

Through the Canadian Genomics Strategy, Canada is investing $175.1 million over seven years in genomics commercialization, data coordination and talent—cementing genomics as a cornerstone of Canada’s bioeconomy. The CGS committed a total of $96 million in investment support for commercialization and adoption through Genome Canada’s Genomics Application Partnership Program (GAPP).

The projects announced today are based across Canada.

...